stars 1 stars 2 stars 3

GenIbet, based in Oeiras, Portugal, is an established CDMO from 2006. GenIbet offers cGMP manufacturing excellence and a comprehensive service that encompasses cell line development, process and analytical development and cGMP production of recombinant proteins, DNA, Viral and Cell products. GenIbet leverages its activities on the extensive expertise in molecular biology, virology, microbial and cell culture of our partner and main shareholder, iBET (Instituto de Biologia Experimental e Tecnológica).

GenIbet Questions

The GenIbet annual revenue was $6.4 million in 2026.

The NAICS codes for GenIbet are [325414, 325, 3254, 32, 32541].

The SIC codes for GenIbet are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users